Disorders of the Central Nervous System and VEMPs: Detecting Lesions in the Vestibulospinal Pathway
As vestibular evoked myogenic potential (VEMP) testing has been regarded as a clinical test of the saccule and its afferents, it has been mainly applied to diseases of the peripheral vestibular system. However, because the neural pathway of VEMPs includes the vestibulospinal tract in the brainstem, it could also detect disorders in the vestibulospinal tract, especially the medial vestibulospinal tract. The application of VEMP testing to diseases that mainly affect the central nervous system (CNS) are discussed in this chapter.
KeywordsMultiple Sclerosis Auditory Brainstem Response Vestibular Evoke Myogenic Potential Myogenic Potential Prolonged Latency
Unable to display preview. Download preview PDF.
- 1.Olek MJ, Dawson DM (2004) Multiple sclerosis and other inflammatory demyelinating diseases of the central nervous system. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J (eds) Neurology in clinical practice. 4th edn. Butterworth Heinemann, Philadelphia, pp 1631–1664Google Scholar
- 3.Chiappa KH (1988) Use of evoked potentials for diagnosis of multiple sclerosis. Neurol Clin 6:1–88Google Scholar
- 10.Subramony SH (2004) Disorders of the cerebellum, including the degenerative ataxias. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J (eds) Neurology in clinical practice. 4th edn. Butterworth Heinemann, Philadelphia, pp 2167–2187Google Scholar
- 18.Brandt T (1999) Vertigo. 2nd edn. Springer-Verlag, LondonGoogle Scholar